NIHR Bristol Cardiovascular Biomedical Research Unit

Unwarranted variation in training in isolated coronary artery bypass grafting in the United Kingdom

OBJECTIVE: Several studies have reported comparable outcomes between trainees and consultants performing isolated coronary artery bypass grafting (CABG). However, the extent to which trainee operating opportunities vary between consultants and hospitals after accounting for patie...

Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event

BackgroundPatients are at increased risk for recurrent ischemic events after an acute coronary syndrome event. Milvexian, an oral factor XIa inhibitor, may reduce the risk of major adverse clinical events with minimal bleeding risk. MethodsIn this phase 3, randomized, placebo-con...